1242338-90-4 Usage
Uses
Used in Pharmaceutical Industry:
6-Difluorobenzonitrile is utilized as an intermediate in the synthesis of various organic compounds, playing a crucial role in the development of new pharmaceutical products.
Used in Agrochemical Industry:
Similarly, in the agrochemical sector, 6-difluorobenzonitrile serves as an intermediate, contributing to the creation of substances that aid in agricultural processes.
Used in Dye and Pigment Production:
6-Difluorobenzonitrile is employed as a building block in the production of dyes and pigments, providing a foundation for the colorants used in various industries.
Used in Specialty Chemicals Manufacturing:
It is also used in the manufacturing of specialty chemicals, where its reactivity and properties are harnessed to create unique and specific chemical products.
Safety Note:
It is important to handle 6-difluorobenzonitrile with care due to its potential harmful effects if ingested, inhaled, or comes into contact with skin and eyes. Proper safety measures should be taken during its use and storage.
Check Digit Verification of cas no
The CAS Registry Mumber 1242338-90-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,2,3,3 and 8 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1242338-90:
(9*1)+(8*2)+(7*4)+(6*2)+(5*3)+(4*3)+(3*8)+(2*9)+(1*0)=134
134 % 10 = 4
So 1242338-90-4 is a valid CAS Registry Number.
1242338-90-4Relevant academic research and scientific papers
POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
-
Page/Page column 187; 188, (2014/07/08)
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Ζ1 and Z4 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
